Phenol Is prohibited for the treatment of pilonidal disease in Germany, why not in the United States?
| dc.authorid | 0000-0002-7110-0717 | |
| dc.contributor.author | Yüksel, Mehmet Eren | |
| dc.contributor.author | Tamer, Funda | |
| dc.date.accessioned | 2019-11-05T10:56:23Z | |
| dc.date.available | 2019-11-05T10:56:23Z | |
| dc.date.issued | 2019 | |
| dc.department | Tıp Fakültesi | |
| dc.description | *Yüksel, Mehmet Eren ( Aksaray, Yazar ) | |
| dc.description.abstract | –We have read “The American Society of Colon and Rectal Surgeons’ Clinical Practice Guidelines for the Management of Pilonidal Disease” with great interest.1 Johnson et al1 stated that phenol application was an effective treatment that might result in rapid and durable healing in patients who had acute or chronic pilonidal disease without abscess. Using phenol in the treatment of pilonidal disease was strongly recommended based on moderate-quality evidence, grade 1B. Grade 1B recommendation necessitated that the benefit of phenol application clearly outweighed risk and burdens or vice versa. Moreover, grade 1B recommendation gave permission to physicians to apply phenol to most patients in most circumstances without reservation. However, Iesalnieks et al,2 who published a German national guideline on the management of pilonidal disease in 2016, reported that the treatment of pilonidal disease with phenol was prohibited by German health authorities (Bundesgesundheitsamt) in 1991.3 Moreover, Bruce et al3 reported that phenol poisoning could occur by skin absorption, vapor inhalation, or ingestion, and, regardless of route of exposure, acute toxicity could result in muscle weakness, convulsion, and coma. | |
| dc.identifier.doi | 10.1097/DCR.0000000000001434 | |
| dc.identifier.endpage | - | en_US |
| dc.identifier.issn | 1530-0358 | |
| dc.identifier.issue | 9 | en_US |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 416 | en_US |
| dc.identifier.uri | https://dx.doi.org/10.1097/DCR.0000000000001434 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12451/6964 | |
| dc.identifier.volume | 62 | en_US |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | NLM (Medline) | |
| dc.relation.ispartof | Diseases of the Colon and Rectum | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Phenol Is Prohibited | |
| dc.subject | Pilonidal Disease in Germany | |
| dc.title | Phenol Is prohibited for the treatment of pilonidal disease in Germany, why not in the United States? | |
| dc.type | Article |
